T h e p h a r m a c o k in etics, b io lo g ic a l e ffects a n d d is tr ib u -
Fo ur th D e p ar tm en t o f Inte r n al M e dicin e, Teikyo U n ive rsity S cho o l o f M e d icine, 74 M izo n oku ch i, Ta ka tsu -ku , K aw a sa ki C ity 21 3, Ja p a n , 2 D ep a rtm e n t o f L a bo ra to ry M ed icin e, a n d
3 D e pa r tm en t o f M e d icin e, M e tab o lism Se ctio n, U n iversity o f C a lifo r n ia Sch o ol of M e d icin e, a n d the Ve teran s A d m in istra tio n M e d ica l C e n te r, Sa n Fra n cisco, C A 9 41 2 1, U SA R e c e n tly, a te st to d e te rm in e th e p la sm a c o n c e n tratio n o f (1® 3 ) -b -D -g lu ca n , a u b iq u it o u s c o nstit u e n t o f f u n g i, h a s b e e n d e ve lo p e d in o rd e r to a llow a n e a r ly d iag n o sis o f d e e p m y c o sis a n d f u n g a l se p sis [1 ,2 ] .
K n o w le d g e o f th e b io lo g ic al a c tiv iti e s o f (1 ® 3 ) -b -D -g lu c a n is e x p a n d in g , w it h th e r e c en t re c og n iti o n th a t th is su b sta n c e c a n sti m u la te th e p r o d u c tio n o f p late le t-a c tiv atin g fa c to r, tu m o r n e c ro sis fa c to r, inte rle u k in -1 ( IL -1 ) , I L -1 r e c ep to r a n ta g o n ist a n d se ve ra l p ro sta g la n d in s in so m e ex p e rim e n ta l m o d e ls [3 ± 5 ] . T h e (1 ® 3 ) -b -D -g lu c a n re c e p to r h a s b e e n id e n tifi e d in m o n o c y te s [6 ] a n d a lso h a s b e e n f o u n d in seve ra l o th e r in fla m m a to r y c ells. T h er e f o re , in th e c a se o f d e e p m y c o s is o r fu n ge m ia , f u n g i c o u ld a c tiv a te c e ll s th r o u g h th e ( 1 ® 3 ) -b -D -g lu c a n re c ep to r, a n d B lo o d sa m p le s ( 3 m l) fo r b lo o d c e ll c o u n ts a n d fo r th e f ra c tio n a ti o n o f c e llu la r a n d p la sm a c o m p o n e n ts w e re a lso d ra w n a t 1 , 5 , 1 0 a n d 3 0 m in , a n d 2 a n d 2 4 h . B lo o d sa m p le s (2 m l) fo r th e F u n g it ec G te st (S e ik ag a k u C o r p o r atio n ) w e r e o b ta in e d at 1 , 2 , 5 , 1 0 , 2 0 , 3 0 , 6 0 a n d 9 0 m in , a n d 2 , 3 , 6 , 1 2 a n d sp le e n , k id n e y, a d r e n a l, lu n g a n d h ea r t w a s stu d ied in a n im a ls k il le d 2 4 h a fte r th e in jec tio n .
Da ta an alysis
A tw o -ta ile d t -te st a n d a n a ly sis o f va ria n c e w it h r ep e ate d m e asu r e s w e re p e rf o rm e d . P < 0 .0 5 wa s c o nsid e re d sig n ific a n t.
Tab le 1. Ph arm acokinetics after an intravenous injection of ( 1® 3 R a p id c le a r a n c e o f g lu c a n b io log ic a l a c tiv ity w a s d e m o n str ate d b y th e G te st f o r b o th lo w -a n d h ig hd o se g r o u p s, w ith T 1/2 v a lu e s o f 4 .1 a n d 2 .1 m in , r esp e c tiv e ly ( F ig . 1 b ). T h e re w a s a g o o d c o rre la tio n b e tw e e n th e iso to p ic a n d th e b io lo g ic m e th o d s. 
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